dc.contributor.author | Elbardisi, Haitham | |
dc.contributor.author | Majzoub, Ahmad | |
dc.contributor.author | Henkel, Ralf | |
dc.date.accessioned | 2021-10-13T10:56:37Z | |
dc.date.available | 2021-10-13T10:56:37Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Elbardisi, H. et al. (2021). Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia. Andrologia, 53(8), e14135. https://doi.org/10.1111/and.14135 | en_US |
dc.identifier.issn | 1439-0272 | |
dc.identifier.uri | https://doi.org/10.1111/and.14135 | |
dc.identifier.uri | http://hdl.handle.net/10566/6897 | |
dc.description.abstract | In this study, we investigated the prevalence of sexual dysfunction among males
with advanced chronic kidney disease and the effect of treating hyperprolactinemia
among these patients. In this prospective study, patients were assessed with history, physical examination, hormonal assessment, and two questionnaires, IIEF and
AIPE. Patients with hyperprolactinemia received treatment with cabergoline 0.5 mg
once per week for 6 months and were re-evaluated. A total of 102 patients were
included in this study, 75 (73.53%) were on hemodialysis, 13 (12.75%) on peritoneal
dialysis and 14 (13.73%) on medical treatment alone. Ninety (88.24%) patients had
premature ejaculation, 85 (83.33%) had anything from mild-to-moderate-to-severe
erectile dysfunction. The incidence of hypogonadism and hyperprolactinemia was
34.4%. Patients treated with cabergoline (n = 26) showed a significant increase in LH
levels (p = .003) and a significant decrease in prolactin levels (p = .003). Testosterone
levels and the incidence of erectile dysfunction or premature ejaculation did not improve significantly. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.subject | Erectile dysfunction | en_US |
dc.subject | Premature ejaculation | en_US |
dc.subject | Sexual dysfunction | en_US |
dc.subject | Patients | en_US |
dc.subject | Kidney disease | en_US |
dc.title | Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia | en_US |
dc.type | Article | en_US |